Infection Intel

>

Latest News

COVID-19   (Adobe Stock 698733477 by Jawed Gfx)
New Study Results Highlight Efficacy of ARCT-154 sa-mRNA Vaccine Against COVID-19

June 12th 2024

Nature Communications published the results of a study on ARCT-154, CSL’s sa-mRNA COVID-19 vaccine. The study showed that it is well-tolerated, immunogenic, and effective against multiple strains.

An image of the blood sampling medical device  (Image credit: Study authors/JAMA)
Infection Intel: Revolutionizing Blood Sampling: Innovative Device Offers Pain-Free and Accessible Solution

May 21st 2024

Infection Control Today's Infection Intel: Staying Ahead With Company Updates and Product Innovations.
Infection Intel: Revolutionizing Pharmaceutical Cold Chain: An Interview With SpaceWalker’s James E. Fesmire, MS

May 17th 2024

Hepatitis B virus  (Adobe Stock 239268660 by Destina)
Advancing Viral Disease Treatment of Recurrent Genital Herpes, Hepatitis B and D Viruses

May 2nd 2024

Weekly Rounds With Infection Control Today
Weekly Rounds: Care Coordination Is Too Complex, Operating Room Traffic, Diabetes, and More

February 9th 2024

More News